146 related articles for article (PubMed ID: 36755436)
21. Aberrantly expressed HIF-1α enhances HCC stem cell-like traits via Wnt/β-catenin signaling activation after insufficient radiofrequency ablation.
Zhang N; Chen R; Cao X; Wang L
J Cancer Res Ther; 2023 Dec; 19(6):1517-1524. PubMed ID: 38156917
[TBL] [Abstract][Full Text] [Related]
22. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
23. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway.
Xu WL; Wang SH; Sun WB; Gao J; Ding XM; Kong J; Xu L; Ke S
BMB Rep; 2019 Apr; 52(4):277-282. PubMed ID: 30940322
[TBL] [Abstract][Full Text] [Related]
24. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
[TBL] [Abstract][Full Text] [Related]
25. Calunduloside E inhibits HepG2 cell proliferation and migration via p38/JNK-HMGB1 signalling axis.
Wang S; Chen X; Cheng J; Cai T; Wu X; Cheng Z; Qi S; Qi Z
J Pharmacol Sci; 2021 Sep; 147(1):18-26. PubMed ID: 34294368
[TBL] [Abstract][Full Text] [Related]
26. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
[TBL] [Abstract][Full Text] [Related]
27. miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma.
Lv G; Wu M; Wang M; Jiang X; Du J; Zhang K; Li D; Ma N; Peng Y; Wang L; Zhou L; Zhao W; Jiao Y; Gao X; Hu Z
Liver Int; 2017 Sep; 37(9):1354-1364. PubMed ID: 28317284
[TBL] [Abstract][Full Text] [Related]
28. NIO-1, A Novel Inhibitor of OCT1, Enhances the Antitumor Action of Radiofrequency Ablation against Hepatocellular Carcinoma.
Yang H; Yang Y; Zou X; Zhang Q; Li X; Zhang C; Wang Y; Ren L
Curr Mol Med; 2024; 24(5):637-647. PubMed ID: 37246325
[TBL] [Abstract][Full Text] [Related]
29. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Jiang T; Zhang X; Ding J; Duan B; Lu S
Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
[TBL] [Abstract][Full Text] [Related]
31. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion.
Tong Y; Yang H; Xu X; Ruan J; Liang M; Wu J; Luo B
Cancer Sci; 2017 Apr; 108(4):753-762. PubMed ID: 28182306
[TBL] [Abstract][Full Text] [Related]
32. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
33. Incomplete radiofrequency ablation promotes the development of CD133
Yuan CW; Wang ZC; Liu K; Liu DJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):416-422. PubMed ID: 30262419
[TBL] [Abstract][Full Text] [Related]
34. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
Wang F; Xu C; Li G; Lv P; Gu J
Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
[TBL] [Abstract][Full Text] [Related]
35. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S
Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691
[TBL] [Abstract][Full Text] [Related]
36. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
37. Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment.
Zhang R; Ma M; Dong G; Yao RR; Li JH; Zheng QD; Dong YY; Ma H; Gao DM; Cui JF; Ren ZG; Chen RX
Cancer Sci; 2017 Sep; 108(9):1778-1786. PubMed ID: 28699238
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
Gao J; Ding F; Liu Q; Yao Y
Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
[TBL] [Abstract][Full Text] [Related]
39. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.
Xiao Y; Sun L; Fu Y; Huang Y; Zhou R; Hu X; Zhou P; Quan J; Li N; Fan XG
BMC Cancer; 2017 Dec; 17(1):857. PubMed ID: 29246127
[TBL] [Abstract][Full Text] [Related]
40. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
Chen L; Ying X; Zhang D; Lai L; Wu F; Tu J; Ji J
Cancer Biother Radiopharm; 2021 Dec; 36(10):820-826. PubMed ID: 32551979
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]